NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that the Centers for Medicare and Medicaid Services (CMS) updated the Outpatient ...
Clinicians may have reservations about using strontium-89 for the treatment of bone metastases because of concerns that it may limit future use of chemotherapy. We assessed the rate of bone marrow ...
Strontium89 (Strontium Chloride Sr-89 injection), a radiopharmaceutical indicated for the relief of bone pain in patients with painful skeletal metastases, has been made available by Q BioMed.
The state Health Department confirmed that strontium-89 from Japan’s nuclear release was detected in Big Island dairy milk after a nationwide high level of cesium also was found in the same April 4 ...
PCa bone metastases. Radium-223, an alpha emitter, but not strontium-89, a beta emitter, improves survival and decreases the risk of symptomatic skeletal events in patients with bone metastases from ...
THE entry of radioactive materials into the food-chain from soils contaminated by intentional or accidental explosion of atomic devices is a potential hazard worthy of considerable attention. Once ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results